Runnymede Capital Advisors »

SPDR S&P Biotech shares owned by Runnymede Capital Advisors

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Runnymede Capital Advisors from 13F filings

Historical chart of Runnymede Capital Advisors investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Runnymede Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Runnymede Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $223k 1.7k 127.73
2025-03-31 $145k 1.8k 81.10

More positions owned by Runnymede Capital Advisors

Proshares Ultra Technology Uit Exchange Traded (ROM)
Invesco Qqq Tr Uit Exchange Traded (QQQ)
Micron Technology Common Stock (MU)
Nvidia Corp Common Stock (NVDA)
Alphabet Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Ishares U.s. Technology Etf Uit Exchange Traded (IYW)
Lam Resh Corp Common Stock (LRCX)
Ishares S&p 100 Etf Uit Exchange Traded (OEF)
Marathon Pete Corp Common Stock (MPC)
Palo Alto Networks Common Stock (PANW)
Blackstone Common Stock (BX)
Alphabet Common Stock (GOOG)

View all positions for Runnymede Capital Advisors

Top funds holding SPDR S&P Biotech

Bnp Paribas Arbitrage, Snc
Susquehanna International
Bank of America Corporation
Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Morgan Stanley
Citigroup
Deep Track Capital
Jane Street
Citadel Advisors
UBS Group
Wells Fargo & Company
Barclays
Leucadia National Corporation
Jain Global

View all funds holding SPDR S&P Biotech